Avodart Cost in South Dakota 2026: Dutasteride Prices, Insurance, and Savings

What Does Avodart Actually Cost in South Dakota in 2026?

Brand Avodart (dutasteride 0.5 mg, GSK) carries a manufacturer list price of approximately $290 per month in 2026, but almost no cash-pay patient in South Dakota pays that. Generic dutasteride 0.5 mg, available at every major chain and most independent pharmacies in the state, averages about $25 per month without insurance. That gap between list price and street price is one of the widest in any drug category.

Dutasteride was first approved by the FDA in 2001 for BPH under the brand name Avodart. [1] Generic versions entered the U.S. market after patent expiration, and competition has driven the retail cash price down sharply. In Sioux Falls, Rapid City, Aberdeen, and smaller rural SD pharmacies, GoodRx-type discount cards regularly place the 30-capsule fill of generic dutasteride 0.5 mg between $18 and $28, depending on the dispensing pharmacy. [2]

The drug is a dual 5-alpha reductase inhibitor, blocking both type I and type II isoenzymes. This distinguishes it from finasteride, which blocks only type II. [3] That pharmacological difference is the reason some clinicians prefer dutasteride for patients who did not respond adequately to finasteride monotherapy for either BPH or androgenetic alopecia. In a 24-month, randomized head-to-head trial (N=153), dutasteride 0.5 mg daily produced statistically greater increases in total hair count versus finasteride 1 mg daily at week 24 (P<0.001). [4]

Prices can shift quarter to quarter. Call the pharmacy directly or run your specific zip code through a pharmacy benefit comparison tool before filling.

South Dakota Medicaid and Dutasteride Coverage

South Dakota Medicaid does not cover Avodart or generic dutasteride for BPH, and it does not cover the drug for off-label androgenetic alopecia. Patients enrolled in South Dakota Medicaid who need a 5-alpha reductase inhibitor for BPH should ask their prescriber whether finasteride is covered under the Medicaid preferred drug list instead, as coverage rules differ by drug and by indication. [5]

The South Dakota Medicaid preferred drug list is administered through the Department of Social Services and is updated periodically. As of 2025, dutasteride does not appear as a covered preferred agent. [6] Prior authorization pathways for non-preferred drugs exist in principle, but approval for dutasteride under current SD Medicaid formulary rules is uncommon.

Patients on dual Medicare and Medicaid (D-SNP or full duals) should check their Part D plan separately. Medicare Part D plans have independent formularies, and some Part D plans do list generic dutasteride as a Tier 1 or Tier 2 drug, which could reduce out-of-pocket cost to as little as $0, $10 per month depending on plan design. [7] The Medicare Plan Finder tool at medicare.gov is the fastest way to compare Part D plans covering dutasteride in South Dakota. [8]

Private Insurance Coverage of Avodart in South Dakota

Most major commercial insurers operating in South Dakota cover generic dutasteride for FDA-approved BPH at Tier 2 or Tier 3. The actual copay ranges from about $10 to $45 per month after deductible, depending on whether the patient has met their annual deductible and the specific plan tier structure. Brand Avodart is almost universally placed on a non-preferred or specialty tier, making the generic the practical choice for insured patients. [9]

South Dakota's largest commercial plan participants include Wellmark Blue Cross Blue Shield, Sanford Health Plan, and Avera Health Plans. Each maintains its own formulary. Wellmark, for instance, typically covers generic dutasteride for BPH after a standard prior authorization confirming a BPH diagnosis. Off-label prescriptions, including dutasteride for male pattern hair loss, are routinely excluded from coverage by commercial plans in South Dakota and most other states. [10]

If your plan denies coverage, a formulary exception or medical necessity appeal is possible. The prescribing clinician must document clinical rationale. Approval rates for formulary exceptions vary. Finasteride is almost always covered as an alternative, so demonstrating prior inadequate response to finasteride strengthens the appeal.

The FDA-approved labeling for dutasteride summarizes its clinical profile in BPH, noting that in the COMBAT trial (N=4,844 to 48 months), combination therapy with dutasteride plus tamsulosin reduced the risk of acute urinary retention and BPH-related surgery by 66% compared with tamsulosin alone (P<0.001). [1] That level of clinical evidence supports medical necessity arguments with payers.

Compounded Dutasteride in South Dakota: Legality and Pricing

Compounded dutasteride dispensed by a state-licensed 503A pharmacy is legal in South Dakota. A 503A pharmacy compounds for individual patients based on a valid prescription from a licensed prescriber. [11] This is distinct from 503B outsourcing facilities, which produce sterile compounded drugs in bulk without patient-specific prescriptions. Compounded dutasteride capsules for oral use fall under 503A rules.

Typical pricing for compounded dutasteride 0.5 mg capsules through a licensed 503A pharmacy runs about $40 per month. That is higher than the $18, $28 cash price for generic dutasteride at retail, so compounding is not always the cheapest route for the standard 0.5 mg oral dose. Where compounding adds clinical value is in custom formulations: topical dutasteride solutions for scalp application, combination capsules pairing dutasteride with minoxidil or other agents, or doses other than the standard 0.5 mg. [12]

Topical dutasteride has attracted meaningful research attention. A vehicle-controlled trial published in the Journal of the American Academy of Dermatology (Eun et al., 2010, N=72) found that topical dutasteride solution applied to the scalp significantly increased hair density in men with androgenetic alopecia compared with vehicle control (P<0.001). [4] Compounding pharmacies can formulate topical dutasteride as a solution or gel for scalp use, which is not commercially available in the United States as a finished drug product.

South Dakota does not impose state-level restrictions on compounded drug formulations beyond federal 503A requirements and standard pharmacy board rules. Patients should verify that the compounding pharmacy holds a current South Dakota Board of Pharmacy license and, for out-of-state mail-order pharmacies, that the pharmacy is licensed to dispense to South Dakota residents. [13]

Telehealth Prescribing of Dutasteride in South Dakota

Dutasteride is legally prescribable via telehealth in South Dakota. State telehealth rules permit audio-video synchronous consultations for new patient prescriptions of non-controlled substances, and dutasteride is not a controlled substance. [14] A prescriber licensed in South Dakota may evaluate a patient via video, confirm the clinical indication (BPH or off-label androgenetic alopecia), and transmit a prescription to a South Dakota pharmacy or a mail-order pharmacy licensed in the state.

HealthRX operates telehealth services in South Dakota. A clinician visit, prescription, and pharmacy routing can be completed in a single session. For BPH, the standard workup before starting dutasteride includes an AUA Symptom Score assessment, a baseline PSA (because dutasteride reduces PSA by approximately 50% at 6 months, which affects cancer screening interpretation), and a review of contraindications. [1] For androgenetic alopecia, the workup is typically lighter but still requires confirming the patient is male (dutasteride is contraindicated in women of childbearing potential), reviewing relevant comorbidities, and discussing sexual side effect risks. [15]

The FDA label carries a boxed warning noting that dutasteride capsules should not be handled by women who are pregnant or may become pregnant due to the risk of fetal harm from 5-alpha reductase inhibition in male fetuses. [1] Telehealth prescribers in South Dakota are expected to document this counseling.

How to Pay the Least for Dutasteride in South Dakota

The cheapest route for most South Dakota cash-pay patients is generic dutasteride 0.5 mg at a high-volume retail pharmacy using a free discount card. Prices at Walmart, Costco, and Sam's Club pharmacies in South Dakota have been documented at $18, $22 per 30-capsule fill. A GoodRx or RxSaver coupon at chains like Walgreens or Rite Aid typically brings the price to $22, $28. [2]

The table below summarizes the cost tiers a South Dakota patient should work through, from lowest to highest:

Tier 1: Retail generic with discount card ($18, $28/month). Best for most patients. No prior authorization, no wait, immediate access.

Tier 2: Part D Medicare plan ($0, $10/month for eligible patients). Requires enrollment in a Part D plan that lists generic dutasteride. Annual open enrollment runs October 15 to December 7. [8]

Tier 3: Commercial insurance with copay ($10, $45/month after deductible). Requires BPH diagnosis coding. Off-label hair loss use is usually excluded.

Tier 4: Compounded dutasteride via 503A pharmacy (~$40/month). Most cost-effective when a non-standard formulation, such as topical or combination, is needed rather than the standard 0.5 mg capsule.

Tier 5: Brand Avodart with manufacturer savings card (variable, may reduce to $50, $60/month for insured patients). GSK has offered savings programs historically, but eligibility depends on insurance status and these programs exclude government insurance beneficiaries including Medicaid and Medicare. [16]

For patients with no insurance at all, the combination of the generic formulation and a free pharmacy discount card is almost always cheaper than pursuing brand Avodart with a manufacturer coupon.

Clinical Evidence Supporting Dutasteride Use

Dutasteride's efficacy for BPH is established across multiple large randomized controlled trials. The ARIA3001, ARIA3002, and ARIB3003 studies collectively demonstrated that dutasteride 0.5 mg daily significantly improved AUA Symptom Scores and reduced prostate volume by approximately 25.7% at 24 months compared with placebo. [17] The drug also reduces acute urinary retention risk. In the 4-year REDUCE trial (N=8,231), dutasteride reduced the risk of prostate biopsy-detectable prostate cancer by 22.8% compared with placebo, though this indication was not FDA-approved and the trial also showed a small numerical increase in high-grade tumors in the dutasteride arm. [18]

For androgenetic alopecia, dutasteride 0.5 mg daily is approved in South Korea and Japan but remains off-label in the United States. The evidence base is meaningful. A 24-week randomized controlled trial by Eun et al. (2010, N=153) published in the Journal of the American Academy of Dermatology showed dutasteride 0.5 mg/day produced a statistically greater increase in target area hair count versus finasteride 1 mg/day at week 24 (P<0.001). [4] A subsequent Cochrane-registered systematic review and meta-analysis confirmed that dutasteride produced greater hair count improvements than finasteride across pooled data, though absolute effect sizes were modest. [19]

The American Urological Association 2021 guidelines on BPH state: "5-alpha reductase inhibitors are recommended for patients with bothersome moderate to severe lower urinary tract symptoms and prostate enlargement." [20] Dutasteride and finasteride are both named as appropriate options within that recommendation.

Sexual side effects, including decreased libido, ejaculatory dysfunction, and erectile dysfunction, occur in approximately 3 to 9% of patients in clinical trials. [1] Post-marketing reports of persistent sexual side effects after discontinuation (post-finasteride or post-dutasteride syndrome) exist but remain under active investigation. [15] Patients should receive this information before starting treatment.

Baseline Labs and Monitoring for South Dakota Patients

Before starting dutasteride, a PSA level should be measured and recorded. Because dutasteride suppresses PSA by roughly 50% within 3 to 6 months of starting therapy, any PSA rise above the nadir during treatment may indicate prostate cancer and warrants further evaluation regardless of the absolute value. [1] The FDA label recommends that clinicians establish a new PSA baseline at 3 to 6 months after initiation.

A serum creatinine or basic metabolic panel is not routinely required for dutasteride, as the drug undergoes hepatic metabolism and is not renally cleared significantly. Patients with severe hepatic impairment should use dutasteride with caution; there are no well-controlled trials in this population. [1]

Monitoring during therapy typically includes a follow-up AUA Symptom Score at 3 to 6 months for BPH patients, annual PSA surveillance with interpretation adjusted for the 50% reduction effect, and assessment of sexual side effects at each visit. The drug's half-life is approximately 5 weeks, meaning full PSA suppression effect takes several months to stabilize. [1]

Patients in rural South Dakota, where access to urology specialists may be limited, may find that a telehealth-based initial evaluation and follow-up are practical. The PSA lab draw can be completed at a local hospital outpatient lab, Sanford clinic, or Avera clinic and shared electronically with the telehealth prescriber. [14]

Dutasteride vs. Finasteride: Cost and Clinical Considerations in South Dakota

Both dutasteride and finasteride are available as low-cost generics in South Dakota. Generic finasteride 1 mg (for hair loss) runs approximately $12, $20 per month, and generic finasteride 5 mg (for BPH) runs approximately $15, $25 per month. Generic dutasteride 0.5 mg runs approximately $18, $28 per month. The price difference is small enough that clinical factors should drive the choice. [2]

Dutasteride's dual 5-alpha reductase inhibition produces greater DHT suppression (approximately 98 to 99% serum DHT reduction versus approximately 70% with finasteride). [3] Whether that translates to meaningful clinical superiority for BPH or hair loss in all patients is debated. For BPH, head-to-head comparative trials are limited. For hair loss, the Eun 2010 data favor dutasteride on hair count endpoints. [4]

From a South Dakota formulary standpoint, finasteride is more likely to be covered under commercial insurance for BPH without prior authorization, while dutasteride may require a PA. For cash-pay patients, the price difference between the two drugs is less than $10 per month in most cases, making clinical preference the deciding factor. [9]

What to Expect at a South Dakota Pharmacy

South Dakota has both large chain pharmacies (Walgreens, CVS, Walmart, Hy-Vee, Costco) and independent community pharmacies, particularly in smaller cities and rural areas. Generic dutasteride 0.5 mg should be stocked at any pharmacy that carries a broad formulary. Rural pharmacies in smaller South Dakota towns may need to order the drug if not routinely stocked, typically a one-to-two day turnaround. [2]

Mail-order pharmacy options, including those operated by major PBMs or telehealth platforms, can ship 90-day supplies to South Dakota addresses. A 90-day supply of generic dutasteride at cash-pay prices typically runs $50, $75, which reduces the per-month cost versus single 30-day fills. [7]

Patients should present their discount card or coupon at the counter before the prescription is filled. Post-fill price adjustments are possible but require reversal and re-adjudication, which takes extra time and not all pharmacy staff will initiate without prompting.